Protea Fund - Sectoral Biotech Opportunities Fund Class IF H Fonds
8,47
CHF
+0,13
CHF
+1,56
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 9,64% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 7,07% |
| Amgen Inc | US0311621009 | 7,05% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 6,61% |
| AstraZeneca PLC ADR | US0463531089 | 4,37% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,08% |
| argenx SE ADR | US04016X1019 | 3,25% |
| Biogen Inc | US09062X1037 | 3,03% |
| Illumina Inc | US4523271090 | 2,38% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,36% |
| Sonstige | 50,15% |